nodes	percent_of_prediction	percent_of_DWPC	metapath
Raltitrexed—Methotrexate—hematologic cancer	0.39	1	CrCtD
Raltitrexed—FPGS—Methotrexate—hematologic cancer	0.0939	0.475	CbGbCtD
Raltitrexed—TYMS—Gemcitabine—hematologic cancer	0.0704	0.356	CbGbCtD
Raltitrexed—Pemetrexed—Methotrexate—hematologic cancer	0.0513	0.2	CrCrCtD
Raltitrexed—Leucovorin—Methotrexate—hematologic cancer	0.0513	0.2	CrCrCtD
Raltitrexed—Pralatrexate—Methotrexate—hematologic cancer	0.0513	0.2	CrCrCtD
Raltitrexed—Folic Acid—Methotrexate—hematologic cancer	0.0513	0.2	CrCrCtD
Raltitrexed—Tetrahydrofolic acid—Methotrexate—hematologic cancer	0.0513	0.2	CrCrCtD
Raltitrexed—TYMS—Methotrexate—hematologic cancer	0.0332	0.168	CbGbCtD
Raltitrexed—FPGS—hematopoietic system—hematologic cancer	0.00225	0.161	CbGeAlD
Raltitrexed—FPGS—blood—hematologic cancer	0.00149	0.107	CbGeAlD
Raltitrexed—TYMS—hematopoietic system—hematologic cancer	0.00148	0.106	CbGeAlD
Raltitrexed—FPGS—lung—hematologic cancer	0.00131	0.0937	CbGeAlD
Raltitrexed—FPGS—testis—hematologic cancer	0.00124	0.0884	CbGeAlD
Raltitrexed—TYMS—gonad—hematologic cancer	0.00112	0.0805	CbGeAlD
Raltitrexed—Tetrahydrofolic acid—FTCD—hematologic cancer	0.000987	0.347	CrCbGaD
Raltitrexed—TYMS—blood—hematologic cancer	0.00098	0.0701	CbGeAlD
Raltitrexed—TYMS—bone marrow—hematologic cancer	0.000948	0.0678	CbGeAlD
Raltitrexed—FPGS—lymph node—hematologic cancer	0.000896	0.0641	CbGeAlD
Raltitrexed—TYMS—lung—hematologic cancer	0.000859	0.0615	CbGeAlD
Raltitrexed—TYMS—testis—hematologic cancer	0.000811	0.058	CbGeAlD
Raltitrexed—TYMS—lymph node—hematologic cancer	0.000588	0.042	CbGeAlD
Raltitrexed—Pemetrexed—DCK—hematologic cancer	0.000469	0.165	CrCbGaD
Raltitrexed—Tetrahydrofolic acid—MTR—hematologic cancer	0.000326	0.115	CrCbGaD
Raltitrexed—TYMS—Nilotinib—Imatinib—hematologic cancer	0.000284	0.139	CbGdCrCtD
Raltitrexed—Leucovorin—ABCC3—hematologic cancer	0.000272	0.0958	CrCbGaD
Raltitrexed—Folic Acid—ABCC3—hematologic cancer	0.000176	0.0618	CrCbGaD
Raltitrexed—TYMS—Vitamin A—Alitretinoin—hematologic cancer	0.000171	0.0837	CbGdCrCtD
Raltitrexed—Methotrexate—ABCC3—hematologic cancer	0.00012	0.0422	CrCbGaD
Raltitrexed—TYMS—Isotretinoin—Alitretinoin—hematologic cancer	0.00012	0.0585	CbGdCrCtD
Raltitrexed—TYMS—Tretinoin—Alitretinoin—hematologic cancer	0.00012	0.0585	CbGdCrCtD
Raltitrexed—TYMS—Podofilox—Teniposide—hematologic cancer	0.000119	0.0583	CbGdCrCtD
Raltitrexed—Tetrahydrofolic acid—MTHFR—hematologic cancer	0.000111	0.0392	CrCbGaD
Raltitrexed—Folic Acid—MTHFR—hematologic cancer	0.000111	0.0392	CrCbGaD
Raltitrexed—TYMS—Menadione—Thalidomide—hematologic cancer	9.05e-05	0.0442	CbGdCrCtD
Raltitrexed—Folic Acid—ABCG2—hematologic cancer	8.53e-05	0.03	CrCbGaD
Raltitrexed—Methotrexate—MTHFR—hematologic cancer	7.62e-05	0.0268	CrCbGaD
Raltitrexed—TYMS—Vincristine—Vinorelbine—hematologic cancer	7.6e-05	0.0371	CbGdCrCtD
Raltitrexed—TYMS—Vinorelbine—Vincristine—hematologic cancer	7.11e-05	0.0347	CbGdCrCtD
Raltitrexed—TYMS—Vinorelbine—Vinblastine—hematologic cancer	7.11e-05	0.0347	CbGdCrCtD
Raltitrexed—TYMS—Podofilox—Etoposide—hematologic cancer	7.1e-05	0.0347	CbGdCrCtD
Raltitrexed—TYMS—Vinblastine—Vinorelbine—hematologic cancer	6.12e-05	0.0299	CbGdCrCtD
Raltitrexed—TYMS—Vincristine—Vinblastine—hematologic cancer	6.08e-05	0.0297	CbGdCrCtD
Raltitrexed—Methotrexate—ABCG2—hematologic cancer	5.83e-05	0.0205	CrCbGaD
Raltitrexed—TYMS—Vinblastine—Vincristine—hematologic cancer	4.89e-05	0.0239	CbGdCrCtD
Raltitrexed—TYMS—Azacitidine—Pentostatin—hematologic cancer	4.64e-05	0.0226	CbGdCrCtD
Raltitrexed—TYMS—Integrated Pancreatic Cancer Pathway—FAS—hematologic cancer	4.47e-05	0.00114	CbGpPWpGaD
Raltitrexed—FPGS—Metabolism—NUP98—hematologic cancer	4.45e-05	0.00113	CbGpPWpGaD
Raltitrexed—TYMS—Cell Cycle, Mitotic—CCND3—hematologic cancer	4.43e-05	0.00113	CbGpPWpGaD
Raltitrexed—FPGS—Disease—H3F3A—hematologic cancer	4.43e-05	0.00112	CbGpPWpGaD
Raltitrexed—TYMS—E2F transcription factor network—MYC—hematologic cancer	4.4e-05	0.00112	CbGpPWpGaD
Raltitrexed—FPGS—Metabolism—ADCY7—hematologic cancer	4.32e-05	0.0011	CbGpPWpGaD
Raltitrexed—FPGS—Metabolism—NCOA3—hematologic cancer	4.32e-05	0.0011	CbGpPWpGaD
Raltitrexed—FPGS—Disease—PRKCZ—hematologic cancer	4.3e-05	0.00109	CbGpPWpGaD
Raltitrexed—TYMS—Circadian rythm related genes—FAS—hematologic cancer	4.29e-05	0.00109	CbGpPWpGaD
Raltitrexed—FPGS—Metabolism—NUP214—hematologic cancer	4.29e-05	0.00109	CbGpPWpGaD
Raltitrexed—FPGS—Disease—CALR—hematologic cancer	4.23e-05	0.00107	CbGpPWpGaD
Raltitrexed—TYMS—Cell Cycle, Mitotic—NUP98—hematologic cancer	4.22e-05	0.00107	CbGpPWpGaD
Raltitrexed—FPGS—Metabolism—MTR—hematologic cancer	4.2e-05	0.00107	CbGpPWpGaD
Raltitrexed—FPGS—Metabolism—ABCG2—hematologic cancer	4.2e-05	0.00107	CbGpPWpGaD
Raltitrexed—TYMS—Cell Cycle—H3F3B—hematologic cancer	4.19e-05	0.00106	CbGpPWpGaD
Raltitrexed—TYMS—Cell Cycle—FOXM1—hematologic cancer	4.19e-05	0.00106	CbGpPWpGaD
Raltitrexed—TYMS—G1/S Transition—CDKN1B—hematologic cancer	4.17e-05	0.00106	CbGpPWpGaD
Raltitrexed—TYMS—Integrated Pancreatic Cancer Pathway—CDK2—hematologic cancer	4.16e-05	0.00106	CbGpPWpGaD
Raltitrexed—FPGS—Disease—PARP1—hematologic cancer	4.16e-05	0.00106	CbGpPWpGaD
Raltitrexed—TYMS—Metabolism—SMPD3—hematologic cancer	4.14e-05	0.00105	CbGpPWpGaD
Raltitrexed—TYMS—Azacitidine—Clofarabine—hematologic cancer	4.13e-05	0.0202	CbGdCrCtD
Raltitrexed—FPGS—Metabolism—ENO2—hematologic cancer	4.12e-05	0.00105	CbGpPWpGaD
Raltitrexed—FPGS—Disease—FBXW7—hematologic cancer	4.09e-05	0.00104	CbGpPWpGaD
Raltitrexed—TYMS—Cell Cycle, Mitotic—NUP214—hematologic cancer	4.07e-05	0.00103	CbGpPWpGaD
Raltitrexed—TYMS—Cell Cycle—NPM1—hematologic cancer	4.03e-05	0.00102	CbGpPWpGaD
Raltitrexed—FPGS—Disease—HDAC2—hematologic cancer	4.01e-05	0.00102	CbGpPWpGaD
Raltitrexed—FPGS—Disease—CXCR4—hematologic cancer	4.01e-05	0.00102	CbGpPWpGaD
Raltitrexed—FPGS—Metabolism—GSTT1—hematologic cancer	4e-05	0.00101	CbGpPWpGaD
Raltitrexed—TYMS—Integrated Pancreatic Cancer Pathway—MAPK14—hematologic cancer	3.99e-05	0.00101	CbGpPWpGaD
Raltitrexed—TYMS—Mitotic G1-G1/S phases—CDKN2A—hematologic cancer	3.97e-05	0.00101	CbGpPWpGaD
Raltitrexed—FPGS—Disease—CD44—hematologic cancer	3.96e-05	0.00101	CbGpPWpGaD
Raltitrexed—TYMS—Cell Cycle—CCND3—hematologic cancer	3.96e-05	0.00101	CbGpPWpGaD
Raltitrexed—TYMS—Integrated Pancreatic Cancer Pathway—ATM—hematologic cancer	3.95e-05	0.001	CbGpPWpGaD
Raltitrexed—TYMS—Integrated Pancreatic Cancer Pathway—CDK4—hematologic cancer	3.93e-05	0.000999	CbGpPWpGaD
Raltitrexed—TYMS—Integrated Pancreatic Cancer Pathway—ESR1—hematologic cancer	3.92e-05	0.000995	CbGpPWpGaD
Raltitrexed—FPGS—Disease—CBL—hematologic cancer	3.91e-05	0.000992	CbGpPWpGaD
Raltitrexed—FPGS—Metabolism—SDC1—hematologic cancer	3.9e-05	0.000992	CbGpPWpGaD
Raltitrexed—TYMS—Azacitidine—Nelarabine—hematologic cancer	3.89e-05	0.019	CbGdCrCtD
Raltitrexed—TYMS—G1/S Transition—CDKN1A—hematologic cancer	3.85e-05	0.000978	CbGpPWpGaD
Raltitrexed—TYMS—Integrated Pancreatic Cancer Pathway—BAD—hematologic cancer	3.82e-05	0.000971	CbGpPWpGaD
Raltitrexed—TYMS—Integrated Pancreatic Cancer Pathway—NFKBIA—hematologic cancer	3.82e-05	0.000971	CbGpPWpGaD
Raltitrexed—TYMS—Retinoblastoma (RB) in Cancer—MYC—hematologic cancer	3.82e-05	0.000971	CbGpPWpGaD
Raltitrexed—TYMS—Circadian rythm related genes—CDK4—hematologic cancer	3.78e-05	0.000959	CbGpPWpGaD
Raltitrexed—TYMS—Cell Cycle—NUP98—hematologic cancer	3.77e-05	0.000958	CbGpPWpGaD
Raltitrexed—FPGS—Disease—HSP90AA1—hematologic cancer	3.73e-05	0.000947	CbGpPWpGaD
Raltitrexed—TYMS—Cell Cycle—NUP214—hematologic cancer	3.64e-05	0.000924	CbGpPWpGaD
Raltitrexed—TYMS—Metabolism—B3GAT1—hematologic cancer	3.62e-05	0.000918	CbGpPWpGaD
Raltitrexed—TYMS—Metabolism—ASNS—hematologic cancer	3.62e-05	0.000918	CbGpPWpGaD
Raltitrexed—TYMS—Metabolism—DCK—hematologic cancer	3.62e-05	0.000918	CbGpPWpGaD
Raltitrexed—FPGS—Disease—STAT1—hematologic cancer	3.59e-05	0.000913	CbGpPWpGaD
Raltitrexed—TYMS—Cell Cycle, Mitotic—SMC1A—hematologic cancer	3.59e-05	0.000911	CbGpPWpGaD
Raltitrexed—TYMS—Cell Cycle, Mitotic—TOP2A—hematologic cancer	3.55e-05	0.000902	CbGpPWpGaD
Raltitrexed—TYMS—Integrated Pancreatic Cancer Pathway—CREB1—hematologic cancer	3.53e-05	0.000895	CbGpPWpGaD
Raltitrexed—TYMS—Cell Cycle, Mitotic—H3F3A—hematologic cancer	3.52e-05	0.000893	CbGpPWpGaD
Raltitrexed—TYMS—Mitotic G1-G1/S phases—CDKN1B—hematologic cancer	3.52e-05	0.000893	CbGpPWpGaD
Raltitrexed—TYMS—Integrated Pancreatic Cancer Pathway—CASP8—hematologic cancer	3.45e-05	0.000876	CbGpPWpGaD
Raltitrexed—TYMS—Integrated Pancreatic Cancer Pathway—CREBBP—hematologic cancer	3.43e-05	0.000872	CbGpPWpGaD
Raltitrexed—TYMS—Metabolism—HDC—hematologic cancer	3.43e-05	0.000871	CbGpPWpGaD
Raltitrexed—TYMS—Circadian rythm related genes—CREB1—hematologic cancer	3.38e-05	0.00086	CbGpPWpGaD
Raltitrexed—FPGS—Disease—GRB2—hematologic cancer	3.36e-05	0.000854	CbGpPWpGaD
Raltitrexed—FPGS—Disease—PDGFA—hematologic cancer	3.35e-05	0.000852	CbGpPWpGaD
Raltitrexed—TYMS—Mitotic G1-G1/S phases—CCND1—hematologic cancer	3.35e-05	0.000852	CbGpPWpGaD
Raltitrexed—TYMS—Cell Cycle—MLH1—hematologic cancer	3.35e-05	0.000851	CbGpPWpGaD
Raltitrexed—FPGS—Metabolism—NQO1—hematologic cancer	3.32e-05	0.000843	CbGpPWpGaD
Raltitrexed—FPGS—Metabolism—CD44—hematologic cancer	3.32e-05	0.000843	CbGpPWpGaD
Raltitrexed—FPGS—Disease—KITLG—hematologic cancer	3.31e-05	0.00084	CbGpPWpGaD
Raltitrexed—TYMS—Cell Cycle, Mitotic—CDK6—hematologic cancer	3.3e-05	0.000839	CbGpPWpGaD
Raltitrexed—TYMS—Integrated Pancreatic Cancer Pathway—MAP2K1—hematologic cancer	3.28e-05	0.000832	CbGpPWpGaD
Raltitrexed—TYMS—Mitotic G1-G1/S phases—CDKN1A—hematologic cancer	3.24e-05	0.000824	CbGpPWpGaD
Raltitrexed—FPGS—Disease—STAT5A—hematologic cancer	3.23e-05	0.000821	CbGpPWpGaD
Raltitrexed—TYMS—Cell Cycle—SMC1A—hematologic cancer	3.21e-05	0.000815	CbGpPWpGaD
Raltitrexed—FPGS—Disease—CDKN2B—hematologic cancer	3.2e-05	0.000814	CbGpPWpGaD
Raltitrexed—TYMS—G1/S Transition—MYC—hematologic cancer	3.19e-05	0.000811	CbGpPWpGaD
Raltitrexed—TYMS—Cell Cycle—TOP2A—hematologic cancer	3.18e-05	0.000807	CbGpPWpGaD
Raltitrexed—TYMS—Cell Cycle—H3F3A—hematologic cancer	3.15e-05	0.000799	CbGpPWpGaD
Raltitrexed—FPGS—Metabolism—CYCS—hematologic cancer	3.14e-05	0.000798	CbGpPWpGaD
Raltitrexed—TYMS—Retinoblastoma (RB) in Cancer—TP53—hematologic cancer	3.14e-05	0.000797	CbGpPWpGaD
Raltitrexed—TYMS—Metabolism—CDA—hematologic cancer	3.14e-05	0.000796	CbGpPWpGaD
Raltitrexed—FPGS—Metabolism—HSP90AA1—hematologic cancer	3.12e-05	0.000793	CbGpPWpGaD
Raltitrexed—TYMS—Integrated Pancreatic Cancer Pathway—FGF2—hematologic cancer	3.12e-05	0.000792	CbGpPWpGaD
Raltitrexed—FPGS—Disease—CD86—hematologic cancer	3.1e-05	0.000787	CbGpPWpGaD
Raltitrexed—FPGS—Disease—HES1—hematologic cancer	3.06e-05	0.000776	CbGpPWpGaD
Raltitrexed—FPGS—Disease—NCOR1—hematologic cancer	3.04e-05	0.000772	CbGpPWpGaD
Raltitrexed—TYMS—Azacitidine—Fludarabine—hematologic cancer	3.03e-05	0.0148	CbGdCrCtD
Raltitrexed—TYMS—Metabolism—PC—hematologic cancer	3.02e-05	0.000766	CbGpPWpGaD
Raltitrexed—FPGS—Disease—FGF1—hematologic cancer	3e-05	0.000763	CbGpPWpGaD
Raltitrexed—TYMS—Cell Cycle, Mitotic—HSP90AA1—hematologic cancer	2.96e-05	0.000752	CbGpPWpGaD
Raltitrexed—FPGS—Disease—FOXO1—hematologic cancer	2.96e-05	0.000752	CbGpPWpGaD
Raltitrexed—TYMS—Integrated Pancreatic Cancer Pathway—BCL2—hematologic cancer	2.96e-05	0.000752	CbGpPWpGaD
Raltitrexed—FPGS—Disease—PDGFRB—hematologic cancer	2.96e-05	0.000751	CbGpPWpGaD
Raltitrexed—TYMS—Cell Cycle—CDK6—hematologic cancer	2.95e-05	0.00075	CbGpPWpGaD
Raltitrexed—TYMS—Integrated Pancreatic Cancer Pathway—MDM2—hematologic cancer	2.92e-05	0.000741	CbGpPWpGaD
Raltitrexed—TYMS—Metabolism—GBA—hematologic cancer	2.91e-05	0.00074	CbGpPWpGaD
Raltitrexed—TYMS—Metabolism—SLC35B2—hematologic cancer	2.91e-05	0.00074	CbGpPWpGaD
Raltitrexed—FPGS—Disease—PDGFRA—hematologic cancer	2.91e-05	0.000739	CbGpPWpGaD
Raltitrexed—FPGS—Disease—PRKCG—hematologic cancer	2.9e-05	0.000737	CbGpPWpGaD
Raltitrexed—FPGS—Disease—JAK1—hematologic cancer	2.9e-05	0.000737	CbGpPWpGaD
Raltitrexed—TYMS—Azacitidine—Cytarabine—hematologic cancer	2.86e-05	0.014	CbGdCrCtD
Raltitrexed—TYMS—Azacitidine—Gemcitabine—hematologic cancer	2.86e-05	0.014	CbGdCrCtD
Raltitrexed—TYMS—Cell Cycle, Mitotic—CCND2—hematologic cancer	2.84e-05	0.000721	CbGpPWpGaD
Raltitrexed—TYMS—Azacitidine—Cladribine—hematologic cancer	2.79e-05	0.0136	CbGdCrCtD
Raltitrexed—FPGS—Metabolism—GSTP1—hematologic cancer	2.77e-05	0.000703	CbGpPWpGaD
Raltitrexed—TYMS—Mitotic G1-G1/S phases—MYC—hematologic cancer	2.69e-05	0.000683	CbGpPWpGaD
Raltitrexed—FPGS—Disease—MTHFR—hematologic cancer	2.69e-05	0.000682	CbGpPWpGaD
Raltitrexed—FPGS—Disease—TERT—hematologic cancer	2.68e-05	0.00068	CbGpPWpGaD
Raltitrexed—FPGS—Disease—HLA-A—hematologic cancer	2.68e-05	0.00068	CbGpPWpGaD
Raltitrexed—TYMS—Metabolism—MTAP—hematologic cancer	2.67e-05	0.000677	CbGpPWpGaD
Raltitrexed—TYMS—Integrated Pancreatic Cancer Pathway—CDKN1B—hematologic cancer	2.66e-05	0.000676	CbGpPWpGaD
Raltitrexed—TYMS—Cell Cycle—HSP90AA1—hematologic cancer	2.65e-05	0.000673	CbGpPWpGaD
Raltitrexed—FPGS—Metabolism—ABCB1—hematologic cancer	2.62e-05	0.000666	CbGpPWpGaD
Raltitrexed—FPGS—Disease—PDGFB—hematologic cancer	2.61e-05	0.000664	CbGpPWpGaD
Raltitrexed—TYMS—Integrated Pancreatic Cancer Pathway—CASP3—hematologic cancer	2.61e-05	0.000663	CbGpPWpGaD
Raltitrexed—FPGS—Disease—TSC2—hematologic cancer	2.55e-05	0.000649	CbGpPWpGaD
Raltitrexed—TYMS—Cell Cycle, Mitotic—CDKN2B—hematologic cancer	2.55e-05	0.000647	CbGpPWpGaD
Raltitrexed—FPGS—Metabolism—NCOR1—hematologic cancer	2.54e-05	0.000646	CbGpPWpGaD
Raltitrexed—FPGS—Metabolism—GSTM1—hematologic cancer	2.54e-05	0.000646	CbGpPWpGaD
Raltitrexed—Methotrexate—ALB—hematologic cancer	2.54e-05	0.00895	CrCbGaD
Raltitrexed—TYMS—Integrated Pancreatic Cancer Pathway—CCND1—hematologic cancer	2.54e-05	0.000645	CbGpPWpGaD
Raltitrexed—TYMS—Cell Cycle—CCND2—hematologic cancer	2.54e-05	0.000645	CbGpPWpGaD
Raltitrexed—TYMS—Integrated Pancreatic Cancer Pathway—JUN—hematologic cancer	2.54e-05	0.000644	CbGpPWpGaD
Raltitrexed—TYMS—Integrated Pancreatic Cancer Pathway—CDKN1A—hematologic cancer	2.46e-05	0.000624	CbGpPWpGaD
Raltitrexed—FPGS—Disease—FGFR3—hematologic cancer	2.46e-05	0.000624	CbGpPWpGaD
Raltitrexed—TYMS—Integrated Pancreatic Cancer Pathway—PTEN—hematologic cancer	2.45e-05	0.000623	CbGpPWpGaD
Raltitrexed—Neutropenia—Doxorubicin—hematologic cancer	2.44e-05	0.00025	CcSEcCtD
Raltitrexed—TYMS—Circadian rythm related genes—JUN—hematologic cancer	2.43e-05	0.000618	CbGpPWpGaD
Raltitrexed—Rash—Thalidomide—hematologic cancer	2.43e-05	0.000249	CcSEcCtD
Raltitrexed—Discomfort—Dexamethasone—hematologic cancer	2.43e-05	0.000249	CcSEcCtD
Raltitrexed—Discomfort—Betamethasone—hematologic cancer	2.43e-05	0.000249	CcSEcCtD
Raltitrexed—Dermatitis—Thalidomide—hematologic cancer	2.43e-05	0.000249	CcSEcCtD
Raltitrexed—Methotrexate—ABCB1—hematologic cancer	2.43e-05	0.00854	CrCbGaD
Raltitrexed—Diarrhoea—Vincristine—hematologic cancer	2.42e-05	0.000248	CcSEcCtD
Raltitrexed—Headache—Thalidomide—hematologic cancer	2.42e-05	0.000247	CcSEcCtD
Raltitrexed—Pain—Prednisolone—hematologic cancer	2.42e-05	0.000247	CcSEcCtD
Raltitrexed—Sweating—Epirubicin—hematologic cancer	2.41e-05	0.000247	CcSEcCtD
Raltitrexed—Asthenia—Gemcitabine—hematologic cancer	2.41e-05	0.000246	CcSEcCtD
Raltitrexed—TYMS—Integrated Pancreatic Cancer Pathway—MAPK8—hematologic cancer	2.4e-05	0.000609	CbGpPWpGaD
Raltitrexed—TYMS—Metabolism—FHL2—hematologic cancer	2.38e-05	0.000603	CbGpPWpGaD
Raltitrexed—Pruritus—Gemcitabine—hematologic cancer	2.37e-05	0.000243	CcSEcCtD
Raltitrexed—Nausea—Thiotepa—hematologic cancer	2.37e-05	0.000242	CcSEcCtD
Raltitrexed—Musculoskeletal discomfort—Triamcinolone—hematologic cancer	2.37e-05	0.000242	CcSEcCtD
Raltitrexed—Weight decreased—Doxorubicin—hematologic cancer	2.36e-05	0.000242	CcSEcCtD
Raltitrexed—Feeling abnormal—Etoposide—hematologic cancer	2.36e-05	0.000242	CcSEcCtD
Raltitrexed—Oedema—Dexamethasone—hematologic cancer	2.36e-05	0.000241	CcSEcCtD
Raltitrexed—Oedema—Betamethasone—hematologic cancer	2.36e-05	0.000241	CcSEcCtD
Raltitrexed—Diarrhoea—Mitoxantrone—hematologic cancer	2.36e-05	0.000241	CcSEcCtD
Raltitrexed—Diarrhoea—Irinotecan—hematologic cancer	2.36e-05	0.000241	CcSEcCtD
Raltitrexed—Vomiting—Carmustine—hematologic cancer	2.36e-05	0.000241	CcSEcCtD
Raltitrexed—TYMS—Circadian rythm related genes—PTEN—hematologic cancer	2.35e-05	0.000598	CbGpPWpGaD
Raltitrexed—Gastrointestinal pain—Etoposide—hematologic cancer	2.34e-05	0.00024	CcSEcCtD
Raltitrexed—Infection—Betamethasone—hematologic cancer	2.34e-05	0.00024	CcSEcCtD
Raltitrexed—Infection—Dexamethasone—hematologic cancer	2.34e-05	0.00024	CcSEcCtD
Raltitrexed—TYMS—Integrated Pancreatic Cancer Pathway—EP300—hematologic cancer	2.34e-05	0.000594	CbGpPWpGaD
Raltitrexed—Rash—Carmustine—hematologic cancer	2.34e-05	0.000239	CcSEcCtD
Raltitrexed—Ill-defined disorder—Prednisone—hematologic cancer	2.33e-05	0.000239	CcSEcCtD
Raltitrexed—Dermatitis—Carmustine—hematologic cancer	2.33e-05	0.000239	CcSEcCtD
Raltitrexed—Vomiting—Alitretinoin—hematologic cancer	2.33e-05	0.000239	CcSEcCtD
Raltitrexed—TYMS—Metabolism—AGRN—hematologic cancer	2.33e-05	0.000592	CbGpPWpGaD
Raltitrexed—FPGS—Disease—BAD—hematologic cancer	2.33e-05	0.000592	CbGpPWpGaD
Raltitrexed—Feeling abnormal—Prednisolone—hematologic cancer	2.33e-05	0.000238	CcSEcCtD
Raltitrexed—Anaemia—Prednisone—hematologic cancer	2.33e-05	0.000238	CcSEcCtD
Raltitrexed—Headache—Carmustine—hematologic cancer	2.32e-05	0.000238	CcSEcCtD
Raltitrexed—Rash—Alitretinoin—hematologic cancer	2.31e-05	0.000237	CcSEcCtD
Raltitrexed—Dermatitis—Alitretinoin—hematologic cancer	2.31e-05	0.000237	CcSEcCtD
Raltitrexed—Thrombocytopenia—Betamethasone—hematologic cancer	2.31e-05	0.000236	CcSEcCtD
Raltitrexed—Thrombocytopenia—Dexamethasone—hematologic cancer	2.31e-05	0.000236	CcSEcCtD
Raltitrexed—FPGS—Disease—NOTCH1—hematologic cancer	2.31e-05	0.000586	CbGpPWpGaD
Raltitrexed—Vomiting—Ifosfamide—hematologic cancer	2.31e-05	0.000236	CcSEcCtD
Raltitrexed—TYMS—Circadian rythm related genes—MAPK8—hematologic cancer	2.3e-05	0.000585	CbGpPWpGaD
Raltitrexed—Headache—Alitretinoin—hematologic cancer	2.3e-05	0.000235	CcSEcCtD
Raltitrexed—Diarrhoea—Gemcitabine—hematologic cancer	2.3e-05	0.000235	CcSEcCtD
Raltitrexed—Nausea—Thalidomide—hematologic cancer	2.29e-05	0.000235	CcSEcCtD
Raltitrexed—Renal failure—Doxorubicin—hematologic cancer	2.29e-05	0.000234	CcSEcCtD
Raltitrexed—Dyspepsia—Triamcinolone—hematologic cancer	2.29e-05	0.000234	CcSEcCtD
Raltitrexed—Rash—Ifosfamide—hematologic cancer	2.29e-05	0.000234	CcSEcCtD
Raltitrexed—Dermatitis—Ifosfamide—hematologic cancer	2.28e-05	0.000234	CcSEcCtD
Raltitrexed—Hyperhidrosis—Dexamethasone—hematologic cancer	2.28e-05	0.000233	CcSEcCtD
Raltitrexed—Hyperhidrosis—Betamethasone—hematologic cancer	2.28e-05	0.000233	CcSEcCtD
Raltitrexed—TYMS—Cell Cycle—CDKN2B—hematologic cancer	2.28e-05	0.000578	CbGpPWpGaD
Raltitrexed—TYMS—Integrated Pancreatic Cancer Pathway—SRC—hematologic cancer	2.27e-05	0.000578	CbGpPWpGaD
Raltitrexed—Stomatitis—Doxorubicin—hematologic cancer	2.27e-05	0.000232	CcSEcCtD
Raltitrexed—Malaise—Prednisone—hematologic cancer	2.27e-05	0.000232	CcSEcCtD
Raltitrexed—Abdominal pain—Etoposide—hematologic cancer	2.26e-05	0.000232	CcSEcCtD
Raltitrexed—Body temperature increased—Etoposide—hematologic cancer	2.26e-05	0.000232	CcSEcCtD
Raltitrexed—Conjunctivitis—Doxorubicin—hematologic cancer	2.26e-05	0.000232	CcSEcCtD
Raltitrexed—FPGS—Disease—CD80—hematologic cancer	2.26e-05	0.000574	CbGpPWpGaD
Raltitrexed—FPGS—Disease—KIT—hematologic cancer	2.26e-05	0.000573	CbGpPWpGaD
Raltitrexed—FPGS—Metabolism—MTHFR—hematologic cancer	2.25e-05	0.000571	CbGpPWpGaD
Raltitrexed—Vomiting—Vincristine—hematologic cancer	2.25e-05	0.00023	CcSEcCtD
Raltitrexed—Anorexia—Dexamethasone—hematologic cancer	2.25e-05	0.00023	CcSEcCtD
Raltitrexed—Anorexia—Betamethasone—hematologic cancer	2.25e-05	0.00023	CcSEcCtD
Raltitrexed—TYMS—Circadian rythm related genes—EP300—hematologic cancer	2.25e-05	0.00057	CbGpPWpGaD
Raltitrexed—Asthenia—Cisplatin—hematologic cancer	2.24e-05	0.00023	CcSEcCtD
Raltitrexed—Sweating—Doxorubicin—hematologic cancer	2.23e-05	0.000229	CcSEcCtD
Raltitrexed—Rash—Vincristine—hematologic cancer	2.23e-05	0.000228	CcSEcCtD
Raltitrexed—Dermatitis—Vincristine—hematologic cancer	2.23e-05	0.000228	CcSEcCtD
Raltitrexed—Pain—Triamcinolone—hematologic cancer	2.22e-05	0.000227	CcSEcCtD
Raltitrexed—FPGS—Disease—PTPN11—hematologic cancer	2.22e-05	0.000563	CbGpPWpGaD
Raltitrexed—Headache—Vincristine—hematologic cancer	2.22e-05	0.000227	CcSEcCtD
Raltitrexed—TYMS—Integrated Pancreatic Cancer Pathway—VEGFA—hematologic cancer	2.22e-05	0.000563	CbGpPWpGaD
Raltitrexed—TYMS—Metabolism—HMMR—hematologic cancer	2.21e-05	0.000561	CbGpPWpGaD
Raltitrexed—TYMS—Metabolism—IDH2—hematologic cancer	2.21e-05	0.000561	CbGpPWpGaD
Raltitrexed—Nausea—Carmustine—hematologic cancer	2.2e-05	0.000225	CcSEcCtD
Raltitrexed—TYMS—Cell Cycle, Mitotic—BIRC5—hematologic cancer	2.2e-05	0.000558	CbGpPWpGaD
Raltitrexed—Vomiting—Irinotecan—hematologic cancer	2.19e-05	0.000224	CcSEcCtD
Raltitrexed—Vomiting—Mitoxantrone—hematologic cancer	2.19e-05	0.000224	CcSEcCtD
Raltitrexed—Nausea—Alitretinoin—hematologic cancer	2.18e-05	0.000223	CcSEcCtD
Raltitrexed—Rash—Irinotecan—hematologic cancer	2.17e-05	0.000222	CcSEcCtD
Raltitrexed—Rash—Mitoxantrone—hematologic cancer	2.17e-05	0.000222	CcSEcCtD
Raltitrexed—Dermatitis—Mitoxantrone—hematologic cancer	2.17e-05	0.000222	CcSEcCtD
Raltitrexed—Dermatitis—Irinotecan—hematologic cancer	2.17e-05	0.000222	CcSEcCtD
Raltitrexed—Headache—Mitoxantrone—hematologic cancer	2.16e-05	0.000221	CcSEcCtD
Raltitrexed—Headache—Irinotecan—hematologic cancer	2.16e-05	0.000221	CcSEcCtD
Raltitrexed—Nausea—Ifosfamide—hematologic cancer	2.15e-05	0.000221	CcSEcCtD
Raltitrexed—Musculoskeletal discomfort—Dexamethasone—hematologic cancer	2.15e-05	0.00022	CcSEcCtD
Raltitrexed—Musculoskeletal discomfort—Betamethasone—hematologic cancer	2.15e-05	0.00022	CcSEcCtD
Raltitrexed—FPGS—Disease—CREB1—hematologic cancer	2.15e-05	0.000545	CbGpPWpGaD
Raltitrexed—Arthralgia—Prednisone—hematologic cancer	2.14e-05	0.000219	CcSEcCtD
Raltitrexed—Feeling abnormal—Triamcinolone—hematologic cancer	2.14e-05	0.000219	CcSEcCtD
Raltitrexed—Diarrhoea—Cisplatin—hematologic cancer	2.14e-05	0.000219	CcSEcCtD
Raltitrexed—Alopecia—Methotrexate—hematologic cancer	2.13e-05	0.000218	CcSEcCtD
Raltitrexed—Vomiting—Gemcitabine—hematologic cancer	2.13e-05	0.000218	CcSEcCtD
Raltitrexed—FPGS—Disease—BRAF—hematologic cancer	2.12e-05	0.000539	CbGpPWpGaD
Raltitrexed—Discomfort—Prednisone—hematologic cancer	2.12e-05	0.000217	CcSEcCtD
Raltitrexed—Rash—Gemcitabine—hematologic cancer	2.12e-05	0.000217	CcSEcCtD
Raltitrexed—Dermatitis—Gemcitabine—hematologic cancer	2.11e-05	0.000216	CcSEcCtD
Raltitrexed—Headache—Gemcitabine—hematologic cancer	2.1e-05	0.000215	CcSEcCtD
Raltitrexed—Nausea—Vincristine—hematologic cancer	2.1e-05	0.000215	CcSEcCtD
Raltitrexed—TYMS—Integrated Pancreatic Cancer Pathway—MAPK3—hematologic cancer	2.1e-05	0.000532	CbGpPWpGaD
Raltitrexed—FPGS—Disease—IL6R—hematologic cancer	2.1e-05	0.000532	CbGpPWpGaD
Raltitrexed—FPGS—Disease—CREBBP—hematologic cancer	2.09e-05	0.000531	CbGpPWpGaD
Raltitrexed—TYMS—Metabolism—ARNTL—hematologic cancer	2.08e-05	0.000527	CbGpPWpGaD
Raltitrexed—Dyspepsia—Dexamethasone—hematologic cancer	2.08e-05	0.000212	CcSEcCtD
Raltitrexed—Dyspepsia—Betamethasone—hematologic cancer	2.08e-05	0.000212	CcSEcCtD
Raltitrexed—Dysgeusia—Methotrexate—hematologic cancer	2.06e-05	0.000211	CcSEcCtD
Raltitrexed—Asthenia—Etoposide—hematologic cancer	2.06e-05	0.00021	CcSEcCtD
Raltitrexed—Body temperature increased—Triamcinolone—hematologic cancer	2.05e-05	0.00021	CcSEcCtD
Raltitrexed—Oedema—Prednisone—hematologic cancer	2.05e-05	0.00021	CcSEcCtD
Raltitrexed—Decreased appetite—Dexamethasone—hematologic cancer	2.05e-05	0.00021	CcSEcCtD
Raltitrexed—Decreased appetite—Betamethasone—hematologic cancer	2.05e-05	0.00021	CcSEcCtD
Raltitrexed—Nausea—Mitoxantrone—hematologic cancer	2.05e-05	0.000209	CcSEcCtD
Raltitrexed—Nausea—Irinotecan—hematologic cancer	2.05e-05	0.000209	CcSEcCtD
Raltitrexed—Infection—Prednisone—hematologic cancer	2.04e-05	0.000209	CcSEcCtD
Raltitrexed—TYMS—Integrated Pancreatic Cancer Pathway—MYC—hematologic cancer	2.04e-05	0.000518	CbGpPWpGaD
Raltitrexed—TYMS—Integrated Pancreatic Cancer Pathway—TGFB1—hematologic cancer	2.03e-05	0.000516	CbGpPWpGaD
Raltitrexed—Pruritus—Etoposide—hematologic cancer	2.03e-05	0.000207	CcSEcCtD
Raltitrexed—TYMS—Metabolism—ACP5—hematologic cancer	2.02e-05	0.000513	CbGpPWpGaD
Raltitrexed—TYMS—Metabolism—CA9—hematologic cancer	2.02e-05	0.000513	CbGpPWpGaD
Raltitrexed—Arrhythmia—Epirubicin—hematologic cancer	2.02e-05	0.000207	CcSEcCtD
Raltitrexed—Pain—Betamethasone—hematologic cancer	2.02e-05	0.000206	CcSEcCtD
Raltitrexed—Pain—Dexamethasone—hematologic cancer	2.02e-05	0.000206	CcSEcCtD
Raltitrexed—TYMS—Cell Cycle, Mitotic—CDK2—hematologic cancer	2.02e-05	0.000512	CbGpPWpGaD
Raltitrexed—Alopecia—Epirubicin—hematologic cancer	2e-05	0.000204	CcSEcCtD
Raltitrexed—FPGS—Disease—MAP2K1—hematologic cancer	2e-05	0.000507	CbGpPWpGaD
Raltitrexed—TYMS—Metabolism—NCOR2—hematologic cancer	1.99e-05	0.000506	CbGpPWpGaD
Raltitrexed—Nausea—Gemcitabine—hematologic cancer	1.99e-05	0.000204	CcSEcCtD
Raltitrexed—Vomiting—Cisplatin—hematologic cancer	1.99e-05	0.000204	CcSEcCtD
Raltitrexed—Hyperhidrosis—Prednisone—hematologic cancer	1.98e-05	0.000203	CcSEcCtD
Raltitrexed—FPGS—Disease—PIK3CD—hematologic cancer	1.98e-05	0.000504	CbGpPWpGaD
Raltitrexed—Rash—Cisplatin—hematologic cancer	1.97e-05	0.000202	CcSEcCtD
Raltitrexed—Dermatitis—Cisplatin—hematologic cancer	1.97e-05	0.000202	CcSEcCtD
Raltitrexed—TYMS—Cell Cycle—BIRC5—hematologic cancer	1.96e-05	0.000499	CbGpPWpGaD
Raltitrexed—Diarrhoea—Etoposide—hematologic cancer	1.96e-05	0.000201	CcSEcCtD
Raltitrexed—Anorexia—Prednisone—hematologic cancer	1.96e-05	0.0002	CcSEcCtD
Raltitrexed—Ill-defined disorder—Methotrexate—hematologic cancer	1.95e-05	0.0002	CcSEcCtD
Raltitrexed—Anaemia—Methotrexate—hematologic cancer	1.94e-05	0.000199	CcSEcCtD
Raltitrexed—Feeling abnormal—Dexamethasone—hematologic cancer	1.94e-05	0.000199	CcSEcCtD
Raltitrexed—Feeling abnormal—Betamethasone—hematologic cancer	1.94e-05	0.000199	CcSEcCtD
Raltitrexed—Gastrointestinal pain—Betamethasone—hematologic cancer	1.93e-05	0.000197	CcSEcCtD
Raltitrexed—Gastrointestinal pain—Dexamethasone—hematologic cancer	1.93e-05	0.000197	CcSEcCtD
Raltitrexed—Dysgeusia—Epirubicin—hematologic cancer	1.93e-05	0.000197	CcSEcCtD
Raltitrexed—TYMS—Cell Cycle, Mitotic—CDK4—hematologic cancer	1.9e-05	0.000484	CbGpPWpGaD
Raltitrexed—TYMS—Cell Cycle—TERT—hematologic cancer	1.9e-05	0.000483	CbGpPWpGaD
Raltitrexed—TYMS—Metabolism—IDH1—hematologic cancer	1.9e-05	0.000482	CbGpPWpGaD
Raltitrexed—FPGS—Disease—FGF2—hematologic cancer	1.9e-05	0.000482	CbGpPWpGaD
Raltitrexed—TYMS—Integrated Pancreatic Cancer Pathway—TNF—hematologic cancer	1.9e-05	0.000482	CbGpPWpGaD
Raltitrexed—Malaise—Methotrexate—hematologic cancer	1.9e-05	0.000194	CcSEcCtD
Raltitrexed—FPGS—Metabolism—PIK3CG—hematologic cancer	1.89e-05	0.00048	CbGpPWpGaD
Raltitrexed—TYMS—Integrated Pancreatic Cancer Pathway—KRAS—hematologic cancer	1.88e-05	0.000478	CbGpPWpGaD
Raltitrexed—Leukopenia—Methotrexate—hematologic cancer	1.88e-05	0.000193	CcSEcCtD
Raltitrexed—TYMS—Metabolism—GSTO1—hematologic cancer	1.88e-05	0.000477	CbGpPWpGaD
Raltitrexed—TYMS—Metabolism—ABCC3—hematologic cancer	1.88e-05	0.000477	CbGpPWpGaD
Raltitrexed—TYMS—Metabolism—TXN—hematologic cancer	1.88e-05	0.000477	CbGpPWpGaD
Raltitrexed—FPGS—Disease—PIK3R1—hematologic cancer	1.87e-05	0.000476	CbGpPWpGaD
Raltitrexed—Musculoskeletal discomfort—Prednisone—hematologic cancer	1.87e-05	0.000191	CcSEcCtD
Raltitrexed—Arrhythmia—Doxorubicin—hematologic cancer	1.87e-05	0.000191	CcSEcCtD
Raltitrexed—Asthenia—Triamcinolone—hematologic cancer	1.86e-05	0.000191	CcSEcCtD
Raltitrexed—Body temperature increased—Dexamethasone—hematologic cancer	1.86e-05	0.000191	CcSEcCtD
Raltitrexed—Body temperature increased—Betamethasone—hematologic cancer	1.86e-05	0.000191	CcSEcCtD
Raltitrexed—Abdominal pain—Betamethasone—hematologic cancer	1.86e-05	0.000191	CcSEcCtD
Raltitrexed—Abdominal pain—Dexamethasone—hematologic cancer	1.86e-05	0.000191	CcSEcCtD
Raltitrexed—Nausea—Cisplatin—hematologic cancer	1.86e-05	0.00019	CcSEcCtD
Raltitrexed—Alopecia—Doxorubicin—hematologic cancer	1.85e-05	0.000189	CcSEcCtD
Raltitrexed—Pruritus—Triamcinolone—hematologic cancer	1.84e-05	0.000188	CcSEcCtD
Raltitrexed—TYMS—Metabolism—SPHK1—hematologic cancer	1.84e-05	0.000467	CbGpPWpGaD
Raltitrexed—Cough—Methotrexate—hematologic cancer	1.83e-05	0.000188	CcSEcCtD
Raltitrexed—Ill-defined disorder—Epirubicin—hematologic cancer	1.83e-05	0.000187	CcSEcCtD
Raltitrexed—Vomiting—Etoposide—hematologic cancer	1.82e-05	0.000186	CcSEcCtD
Raltitrexed—FPGS—Disease—JAK2—hematologic cancer	1.82e-05	0.000462	CbGpPWpGaD
Raltitrexed—Anaemia—Epirubicin—hematologic cancer	1.82e-05	0.000186	CcSEcCtD
Raltitrexed—Dyspepsia—Prednisone—hematologic cancer	1.81e-05	0.000185	CcSEcCtD
Raltitrexed—Rash—Etoposide—hematologic cancer	1.81e-05	0.000185	CcSEcCtD
Raltitrexed—Dermatitis—Etoposide—hematologic cancer	1.8e-05	0.000185	CcSEcCtD
Raltitrexed—TYMS—Cell Cycle—CDK2—hematologic cancer	1.8e-05	0.000458	CbGpPWpGaD
Raltitrexed—Headache—Etoposide—hematologic cancer	1.79e-05	0.000184	CcSEcCtD
Raltitrexed—Arthralgia—Methotrexate—hematologic cancer	1.79e-05	0.000183	CcSEcCtD
Raltitrexed—Decreased appetite—Prednisone—hematologic cancer	1.78e-05	0.000183	CcSEcCtD
Raltitrexed—Dysgeusia—Doxorubicin—hematologic cancer	1.78e-05	0.000183	CcSEcCtD
Raltitrexed—Rash—Prednisolone—hematologic cancer	1.78e-05	0.000182	CcSEcCtD
Raltitrexed—Dermatitis—Prednisolone—hematologic cancer	1.78e-05	0.000182	CcSEcCtD
Raltitrexed—FPGS—Disease—MDM2—hematologic cancer	1.78e-05	0.000451	CbGpPWpGaD
Raltitrexed—Malaise—Epirubicin—hematologic cancer	1.77e-05	0.000182	CcSEcCtD
Raltitrexed—Headache—Prednisolone—hematologic cancer	1.77e-05	0.000181	CcSEcCtD
Raltitrexed—Discomfort—Methotrexate—hematologic cancer	1.77e-05	0.000181	CcSEcCtD
Raltitrexed—TYMS—Metabolism—UGT1A1—hematologic cancer	1.77e-05	0.000448	CbGpPWpGaD
Raltitrexed—TYMS—Clobetasol propionate—Betamethasone—hematologic cancer	1.76e-05	0.00861	CbGdCrCtD
Raltitrexed—TYMS—Clobetasol propionate—Dexamethasone—hematologic cancer	1.76e-05	0.00861	CbGdCrCtD
Raltitrexed—Leukopenia—Epirubicin—hematologic cancer	1.76e-05	0.00018	CcSEcCtD
Raltitrexed—Constipation—Prednisone—hematologic cancer	1.76e-05	0.00018	CcSEcCtD
Raltitrexed—FPGS—Metabolism—CREBBP—hematologic cancer	1.75e-05	0.000445	CbGpPWpGaD
Raltitrexed—TYMS—Flunisolide—Betamethasone—hematologic cancer	1.74e-05	0.0085	CbGdCrCtD
Raltitrexed—TYMS—Flunisolide—Dexamethasone—hematologic cancer	1.74e-05	0.0085	CbGdCrCtD
Raltitrexed—TYMS—Integrated Pancreatic Cancer Pathway—PIK3CA—hematologic cancer	1.73e-05	0.000439	CbGpPWpGaD
Raltitrexed—FPGS—Disease—PIK3CB—hematologic cancer	1.73e-05	0.000439	CbGpPWpGaD
Raltitrexed—FPGS—Disease—MTOR—hematologic cancer	1.73e-05	0.000439	CbGpPWpGaD
Raltitrexed—FPGS—Disease—CD4—hematologic cancer	1.73e-05	0.000438	CbGpPWpGaD
Raltitrexed—TYMS—Clobetasol propionate—Triamcinolone—hematologic cancer	1.72e-05	0.00842	CbGdCrCtD
Raltitrexed—TYMS—Triamcinolone—Betamethasone—hematologic cancer	1.72e-05	0.00842	CbGdCrCtD
Raltitrexed—TYMS—Triamcinolone—Dexamethasone—hematologic cancer	1.72e-05	0.00842	CbGdCrCtD
Raltitrexed—TYMS—Metabolism—CRABP1—hematologic cancer	1.72e-05	0.000436	CbGpPWpGaD
Raltitrexed—TYMS—Metabolism—SLC22A1—hematologic cancer	1.72e-05	0.000436	CbGpPWpGaD
Raltitrexed—Cough—Epirubicin—hematologic cancer	1.72e-05	0.000176	CcSEcCtD
Raltitrexed—TYMS—Cell Cycle—ATM—hematologic cancer	1.71e-05	0.000434	CbGpPWpGaD
Raltitrexed—Infection—Methotrexate—hematologic cancer	1.7e-05	0.000175	CcSEcCtD
Raltitrexed—TYMS—Cell Cycle—CDK4—hematologic cancer	1.7e-05	0.000433	CbGpPWpGaD
Raltitrexed—Nausea—Etoposide—hematologic cancer	1.7e-05	0.000174	CcSEcCtD
Raltitrexed—TYMS—Flunisolide—Triamcinolone—hematologic cancer	1.7e-05	0.00831	CbGdCrCtD
Raltitrexed—Feeling abnormal—Prednisone—hematologic cancer	1.69e-05	0.000173	CcSEcCtD
Raltitrexed—Asthenia—Dexamethasone—hematologic cancer	1.69e-05	0.000173	CcSEcCtD
Raltitrexed—Asthenia—Betamethasone—hematologic cancer	1.69e-05	0.000173	CcSEcCtD
Raltitrexed—Ill-defined disorder—Doxorubicin—hematologic cancer	1.69e-05	0.000173	CcSEcCtD
Raltitrexed—Anaemia—Doxorubicin—hematologic cancer	1.68e-05	0.000172	CcSEcCtD
Raltitrexed—TYMS—Fluticasone Propionate—Betamethasone—hematologic cancer	1.68e-05	0.00821	CbGdCrCtD
Raltitrexed—TYMS—Fluticasone Propionate—Dexamethasone—hematologic cancer	1.68e-05	0.00821	CbGdCrCtD
Raltitrexed—Thrombocytopenia—Methotrexate—hematologic cancer	1.68e-05	0.000172	CcSEcCtD
Raltitrexed—Gastrointestinal pain—Prednisone—hematologic cancer	1.68e-05	0.000172	CcSEcCtD
Raltitrexed—Nausea—Prednisolone—hematologic cancer	1.68e-05	0.000172	CcSEcCtD
Raltitrexed—Arthralgia—Epirubicin—hematologic cancer	1.68e-05	0.000171	CcSEcCtD
Raltitrexed—TYMS—Metabolism—ALOX5—hematologic cancer	1.67e-05	0.000425	CbGpPWpGaD
Raltitrexed—TYMS—Integrated Pancreatic Cancer Pathway—TP53—hematologic cancer	1.67e-05	0.000425	CbGpPWpGaD
Raltitrexed—Pruritus—Betamethasone—hematologic cancer	1.67e-05	0.000171	CcSEcCtD
Raltitrexed—Pruritus—Dexamethasone—hematologic cancer	1.67e-05	0.000171	CcSEcCtD
Raltitrexed—FPGS—Metabolism—PIK3CD—hematologic cancer	1.66e-05	0.000422	CbGpPWpGaD
Raltitrexed—Hyperhidrosis—Methotrexate—hematologic cancer	1.66e-05	0.00017	CcSEcCtD
Raltitrexed—TYMS—Cell Cycle, Mitotic—RB1—hematologic cancer	1.66e-05	0.000421	CbGpPWpGaD
Raltitrexed—Discomfort—Epirubicin—hematologic cancer	1.66e-05	0.000169	CcSEcCtD
Raltitrexed—Vomiting—Triamcinolone—hematologic cancer	1.65e-05	0.000169	CcSEcCtD
Raltitrexed—TYMS—Fluticasone Propionate—Triamcinolone—hematologic cancer	1.64e-05	0.00802	CbGdCrCtD
Raltitrexed—Malaise—Doxorubicin—hematologic cancer	1.64e-05	0.000168	CcSEcCtD
Raltitrexed—FPGS—Metabolism—ALB—hematologic cancer	1.64e-05	0.000416	CbGpPWpGaD
Raltitrexed—Rash—Triamcinolone—hematologic cancer	1.64e-05	0.000168	CcSEcCtD
Raltitrexed—Dermatitis—Triamcinolone—hematologic cancer	1.64e-05	0.000168	CcSEcCtD
Raltitrexed—Anorexia—Methotrexate—hematologic cancer	1.64e-05	0.000167	CcSEcCtD
Raltitrexed—TYMS—Clobetasol propionate—Prednisone—hematologic cancer	1.64e-05	0.00799	CbGdCrCtD
Raltitrexed—Leukopenia—Doxorubicin—hematologic cancer	1.63e-05	0.000167	CcSEcCtD
Raltitrexed—Headache—Triamcinolone—hematologic cancer	1.63e-05	0.000167	CcSEcCtD
Raltitrexed—Body temperature increased—Prednisone—hematologic cancer	1.62e-05	0.000166	CcSEcCtD
Raltitrexed—Abdominal pain—Prednisone—hematologic cancer	1.62e-05	0.000166	CcSEcCtD
Raltitrexed—FPGS—Disease—CDKN1B—hematologic cancer	1.62e-05	0.000412	CbGpPWpGaD
Raltitrexed—TYMS—Metabolism—NUP98—hematologic cancer	1.62e-05	0.000412	CbGpPWpGaD
Raltitrexed—TYMS—Flunisolide—Prednisone—hematologic cancer	1.61e-05	0.00788	CbGdCrCtD
Raltitrexed—Diarrhoea—Dexamethasone—hematologic cancer	1.61e-05	0.000165	CcSEcCtD
Raltitrexed—Diarrhoea—Betamethasone—hematologic cancer	1.61e-05	0.000165	CcSEcCtD
Raltitrexed—TYMS—Circadian rythm related genes—TP53—hematologic cancer	1.61e-05	0.000408	CbGpPWpGaD
Raltitrexed—Oedema—Epirubicin—hematologic cancer	1.61e-05	0.000164	CcSEcCtD
Raltitrexed—TYMS—Triamcinolone—Prednisone—hematologic cancer	1.6e-05	0.0078	CbGdCrCtD
Raltitrexed—TYMS—Clobetasol propionate—Prednisolone—hematologic cancer	1.6e-05	0.0078	CbGdCrCtD
Raltitrexed—Infection—Epirubicin—hematologic cancer	1.6e-05	0.000163	CcSEcCtD
Raltitrexed—Cough—Doxorubicin—hematologic cancer	1.59e-05	0.000163	CcSEcCtD
Raltitrexed—TYMS—Diflorasone—Dexamethasone—hematologic cancer	1.59e-05	0.00776	CbGdCrCtD
Raltitrexed—TYMS—Diflorasone—Betamethasone—hematologic cancer	1.59e-05	0.00776	CbGdCrCtD
Raltitrexed—TYMS—Flunisolide—Prednisolone—hematologic cancer	1.58e-05	0.0077	CbGdCrCtD
Raltitrexed—TYMS—Metabolism—ADCY7—hematologic cancer	1.57e-05	0.0004	CbGpPWpGaD
Raltitrexed—TYMS—Metabolism—NCOA3—hematologic cancer	1.57e-05	0.0004	CbGpPWpGaD
Raltitrexed—Thrombocytopenia—Epirubicin—hematologic cancer	1.57e-05	0.000161	CcSEcCtD
Raltitrexed—FPGS—Metabolism—PIK3R1—hematologic cancer	1.57e-05	0.000398	CbGpPWpGaD
Raltitrexed—Musculoskeletal discomfort—Methotrexate—hematologic cancer	1.56e-05	0.00016	CcSEcCtD
Raltitrexed—TYMS—Metabolism—NUP214—hematologic cancer	1.56e-05	0.000397	CbGpPWpGaD
Raltitrexed—TYMS—Triamcinolone—Prednisolone—hematologic cancer	1.56e-05	0.00762	CbGdCrCtD
Raltitrexed—Hyperhidrosis—Epirubicin—hematologic cancer	1.55e-05	0.000159	CcSEcCtD
Raltitrexed—TYMS—Diflorasone—Triamcinolone—hematologic cancer	1.55e-05	0.00758	CbGdCrCtD
Raltitrexed—Arthralgia—Doxorubicin—hematologic cancer	1.55e-05	0.000159	CcSEcCtD
Raltitrexed—Nausea—Triamcinolone—hematologic cancer	1.54e-05	0.000158	CcSEcCtD
Raltitrexed—Discomfort—Doxorubicin—hematologic cancer	1.53e-05	0.000157	CcSEcCtD
Raltitrexed—TYMS—Metabolism—MTR—hematologic cancer	1.53e-05	0.000389	CbGpPWpGaD
Raltitrexed—TYMS—Metabolism—ABCG2—hematologic cancer	1.53e-05	0.000389	CbGpPWpGaD
Raltitrexed—Anorexia—Epirubicin—hematologic cancer	1.53e-05	0.000157	CcSEcCtD
Raltitrexed—Dyspepsia—Methotrexate—hematologic cancer	1.51e-05	0.000155	CcSEcCtD
Raltitrexed—TYMS—Metabolism—ENO2—hematologic cancer	1.5e-05	0.000381	CbGpPWpGaD
Raltitrexed—Vomiting—Dexamethasone—hematologic cancer	1.5e-05	0.000153	CcSEcCtD
Raltitrexed—Vomiting—Betamethasone—hematologic cancer	1.5e-05	0.000153	CcSEcCtD
Raltitrexed—FPGS—Disease—CDKN1A—hematologic cancer	1.5e-05	0.00038	CbGpPWpGaD
Raltitrexed—FPGS—Disease—PTEN—hematologic cancer	1.49e-05	0.000379	CbGpPWpGaD
Raltitrexed—Decreased appetite—Methotrexate—hematologic cancer	1.49e-05	0.000153	CcSEcCtD
Raltitrexed—Rash—Dexamethasone—hematologic cancer	1.49e-05	0.000152	CcSEcCtD
Raltitrexed—Rash—Betamethasone—hematologic cancer	1.49e-05	0.000152	CcSEcCtD
Raltitrexed—Oedema—Doxorubicin—hematologic cancer	1.49e-05	0.000152	CcSEcCtD
Raltitrexed—Dermatitis—Dexamethasone—hematologic cancer	1.49e-05	0.000152	CcSEcCtD
Raltitrexed—Dermatitis—Betamethasone—hematologic cancer	1.49e-05	0.000152	CcSEcCtD
Raltitrexed—TYMS—Cell Cycle—RB1—hematologic cancer	1.48e-05	0.000376	CbGpPWpGaD
Raltitrexed—Headache—Betamethasone—hematologic cancer	1.48e-05	0.000151	CcSEcCtD
Raltitrexed—Headache—Dexamethasone—hematologic cancer	1.48e-05	0.000151	CcSEcCtD
Raltitrexed—Infection—Doxorubicin—hematologic cancer	1.48e-05	0.000151	CcSEcCtD
Raltitrexed—Asthenia—Prednisone—hematologic cancer	1.47e-05	0.000151	CcSEcCtD
Raltitrexed—TYMS—Diflorasone—Prednisone—hematologic cancer	1.47e-05	0.00719	CbGdCrCtD
Raltitrexed—TYMS—Circadian rythm related genes—IL6—hematologic cancer	1.47e-05	0.000374	CbGpPWpGaD
Raltitrexed—Pain—Methotrexate—hematologic cancer	1.47e-05	0.00015	CcSEcCtD
Raltitrexed—Musculoskeletal discomfort—Epirubicin—hematologic cancer	1.46e-05	0.00015	CcSEcCtD
Raltitrexed—TYMS—Metabolism—GSTT1—hematologic cancer	1.46e-05	0.00037	CbGpPWpGaD
Raltitrexed—TYMS—Cell Cycle, Mitotic—CDKN2A—hematologic cancer	1.46e-05	0.00037	CbGpPWpGaD
Raltitrexed—Thrombocytopenia—Doxorubicin—hematologic cancer	1.45e-05	0.000149	CcSEcCtD
Raltitrexed—Pruritus—Prednisone—hematologic cancer	1.45e-05	0.000149	CcSEcCtD
Raltitrexed—FPGS—Metabolism—PIK3CB—hematologic cancer	1.45e-05	0.000368	CbGpPWpGaD
Raltitrexed—TYMS—Diflorasone—Prednisolone—hematologic cancer	1.44e-05	0.00702	CbGdCrCtD
Raltitrexed—Hyperhidrosis—Doxorubicin—hematologic cancer	1.44e-05	0.000147	CcSEcCtD
Raltitrexed—FPGS—Disease—EP300—hematologic cancer	1.42e-05	0.000362	CbGpPWpGaD
Raltitrexed—TYMS—Metabolism—SDC1—hematologic cancer	1.42e-05	0.000361	CbGpPWpGaD
Raltitrexed—Anorexia—Doxorubicin—hematologic cancer	1.42e-05	0.000145	CcSEcCtD
Raltitrexed—Feeling abnormal—Methotrexate—hematologic cancer	1.41e-05	0.000145	CcSEcCtD
Raltitrexed—Dyspepsia—Epirubicin—hematologic cancer	1.41e-05	0.000145	CcSEcCtD
Raltitrexed—TYMS—Integrated Pancreatic Cancer Pathway—AKT1—hematologic cancer	1.41e-05	0.000359	CbGpPWpGaD
Raltitrexed—Diarrhoea—Prednisone—hematologic cancer	1.4e-05	0.000144	CcSEcCtD
Raltitrexed—Gastrointestinal pain—Methotrexate—hematologic cancer	1.4e-05	0.000144	CcSEcCtD
Raltitrexed—Nausea—Dexamethasone—hematologic cancer	1.4e-05	0.000143	CcSEcCtD
Raltitrexed—Nausea—Betamethasone—hematologic cancer	1.4e-05	0.000143	CcSEcCtD
Raltitrexed—Decreased appetite—Epirubicin—hematologic cancer	1.4e-05	0.000143	CcSEcCtD
Raltitrexed—TYMS—Budesonide—Dexamethasone—hematologic cancer	1.39e-05	0.0068	CbGdCrCtD
Raltitrexed—TYMS—Budesonide—Betamethasone—hematologic cancer	1.39e-05	0.0068	CbGdCrCtD
Raltitrexed—FPGS—Disease—SRC—hematologic cancer	1.39e-05	0.000352	CbGpPWpGaD
Raltitrexed—Pain—Epirubicin—hematologic cancer	1.37e-05	0.000141	CcSEcCtD
Raltitrexed—Constipation—Epirubicin—hematologic cancer	1.37e-05	0.000141	CcSEcCtD
Raltitrexed—TYMS—Budesonide—Triamcinolone—hematologic cancer	1.36e-05	0.00664	CbGdCrCtD
Raltitrexed—Abdominal pain—Methotrexate—hematologic cancer	1.36e-05	0.000139	CcSEcCtD
Raltitrexed—Body temperature increased—Methotrexate—hematologic cancer	1.36e-05	0.000139	CcSEcCtD
Raltitrexed—Musculoskeletal discomfort—Doxorubicin—hematologic cancer	1.35e-05	0.000139	CcSEcCtD
Raltitrexed—FPGS—Disease—STAT3—hematologic cancer	1.34e-05	0.000339	CbGpPWpGaD
Raltitrexed—FPGS—Disease—NRAS—hematologic cancer	1.33e-05	0.000339	CbGpPWpGaD
Raltitrexed—Feeling abnormal—Epirubicin—hematologic cancer	1.32e-05	0.000135	CcSEcCtD
Raltitrexed—Gastrointestinal pain—Epirubicin—hematologic cancer	1.31e-05	0.000134	CcSEcCtD
Raltitrexed—Dyspepsia—Doxorubicin—hematologic cancer	1.31e-05	0.000134	CcSEcCtD
Raltitrexed—Vomiting—Prednisone—hematologic cancer	1.31e-05	0.000134	CcSEcCtD
Raltitrexed—TYMS—Cell Cycle—CDKN2A—hematologic cancer	1.3e-05	0.000331	CbGpPWpGaD
Raltitrexed—Rash—Prednisone—hematologic cancer	1.29e-05	0.000133	CcSEcCtD
Raltitrexed—Dermatitis—Prednisone—hematologic cancer	1.29e-05	0.000132	CcSEcCtD
Raltitrexed—Decreased appetite—Doxorubicin—hematologic cancer	1.29e-05	0.000132	CcSEcCtD
Raltitrexed—TYMS—Budesonide—Prednisone—hematologic cancer	1.29e-05	0.00631	CbGdCrCtD
Raltitrexed—TYMS—Cell Cycle, Mitotic—CDKN1B—hematologic cancer	1.29e-05	0.000327	CbGpPWpGaD
Raltitrexed—Headache—Prednisone—hematologic cancer	1.29e-05	0.000132	CcSEcCtD
Raltitrexed—FPGS—Disease—MAPK3—hematologic cancer	1.28e-05	0.000324	CbGpPWpGaD
Raltitrexed—Constipation—Doxorubicin—hematologic cancer	1.27e-05	0.00013	CcSEcCtD
Raltitrexed—Pain—Doxorubicin—hematologic cancer	1.27e-05	0.00013	CcSEcCtD
Raltitrexed—Body temperature increased—Epirubicin—hematologic cancer	1.27e-05	0.00013	CcSEcCtD
Raltitrexed—Abdominal pain—Epirubicin—hematologic cancer	1.27e-05	0.00013	CcSEcCtD
Raltitrexed—TYMS—Cell Cycle—MDM2—hematologic cancer	1.26e-05	0.000321	CbGpPWpGaD
Raltitrexed—TYMS—Budesonide—Prednisolone—hematologic cancer	1.26e-05	0.00615	CbGdCrCtD
Raltitrexed—FPGS—Metabolism—PTEN—hematologic cancer	1.25e-05	0.000318	CbGpPWpGaD
Raltitrexed—FPGS—Disease—MYC—hematologic cancer	1.24e-05	0.000315	CbGpPWpGaD
Raltitrexed—FPGS—Disease—TGFB1—hematologic cancer	1.24e-05	0.000315	CbGpPWpGaD
Raltitrexed—TYMS—Danazol—Prednisone—hematologic cancer	1.24e-05	0.00604	CbGdCrCtD
Raltitrexed—Asthenia—Methotrexate—hematologic cancer	1.23e-05	0.000126	CcSEcCtD
Raltitrexed—TYMS—Cell Cycle, Mitotic—CCND1—hematologic cancer	1.23e-05	0.000312	CbGpPWpGaD
Raltitrexed—Feeling abnormal—Doxorubicin—hematologic cancer	1.22e-05	0.000125	CcSEcCtD
Raltitrexed—Nausea—Prednisone—hematologic cancer	1.22e-05	0.000125	CcSEcCtD
Raltitrexed—Gastrointestinal pain—Doxorubicin—hematologic cancer	1.22e-05	0.000124	CcSEcCtD
Raltitrexed—Pruritus—Methotrexate—hematologic cancer	1.21e-05	0.000124	CcSEcCtD
Raltitrexed—TYMS—Metabolism—NQO1—hematologic cancer	1.21e-05	0.000307	CbGpPWpGaD
Raltitrexed—TYMS—Metabolism—CD44—hematologic cancer	1.21e-05	0.000307	CbGpPWpGaD
Raltitrexed—FPGS—Metabolism—EP300—hematologic cancer	1.19e-05	0.000303	CbGpPWpGaD
Raltitrexed—TYMS—Cell Cycle, Mitotic—CDKN1A—hematologic cancer	1.19e-05	0.000302	CbGpPWpGaD
Raltitrexed—Body temperature increased—Doxorubicin—hematologic cancer	1.17e-05	0.00012	CcSEcCtD
Raltitrexed—Abdominal pain—Doxorubicin—hematologic cancer	1.17e-05	0.00012	CcSEcCtD
Raltitrexed—Diarrhoea—Methotrexate—hematologic cancer	1.17e-05	0.00012	CcSEcCtD
Raltitrexed—TYMS—Cell Cycle—CDKN1B—hematologic cancer	1.15e-05	0.000293	CbGpPWpGaD
Raltitrexed—Asthenia—Epirubicin—hematologic cancer	1.15e-05	0.000118	CcSEcCtD
Raltitrexed—FPGS—Disease—KRAS—hematologic cancer	1.15e-05	0.000291	CbGpPWpGaD
Raltitrexed—TYMS—Metabolism—CYCS—hematologic cancer	1.15e-05	0.000291	CbGpPWpGaD
Raltitrexed—TYMS—Metabolism—HSP90AA1—hematologic cancer	1.14e-05	0.000289	CbGpPWpGaD
Raltitrexed—Pruritus—Epirubicin—hematologic cancer	1.14e-05	0.000116	CcSEcCtD
Raltitrexed—TYMS—Cell Cycle, Mitotic—EP300—hematologic cancer	1.13e-05	0.000288	CbGpPWpGaD
Raltitrexed—TYMS—Cell Cycle—CCND1—hematologic cancer	1.1e-05	0.000279	CbGpPWpGaD
Raltitrexed—Diarrhoea—Epirubicin—hematologic cancer	1.1e-05	0.000112	CcSEcCtD
Raltitrexed—Vomiting—Methotrexate—hematologic cancer	1.09e-05	0.000112	CcSEcCtD
Raltitrexed—Rash—Methotrexate—hematologic cancer	1.08e-05	0.000111	CcSEcCtD
Raltitrexed—Dermatitis—Methotrexate—hematologic cancer	1.08e-05	0.000111	CcSEcCtD
Raltitrexed—Headache—Methotrexate—hematologic cancer	1.07e-05	0.00011	CcSEcCtD
Raltitrexed—Asthenia—Doxorubicin—hematologic cancer	1.07e-05	0.000109	CcSEcCtD
Raltitrexed—TYMS—Cell Cycle—CDKN1A—hematologic cancer	1.06e-05	0.00027	CbGpPWpGaD
Raltitrexed—FPGS—Disease—PIK3CA—hematologic cancer	1.05e-05	0.000268	CbGpPWpGaD
Raltitrexed—Pruritus—Doxorubicin—hematologic cancer	1.05e-05	0.000108	CcSEcCtD
Raltitrexed—Vomiting—Epirubicin—hematologic cancer	1.02e-05	0.000105	CcSEcCtD
Raltitrexed—Nausea—Methotrexate—hematologic cancer	1.02e-05	0.000104	CcSEcCtD
Raltitrexed—Diarrhoea—Doxorubicin—hematologic cancer	1.02e-05	0.000104	CcSEcCtD
Raltitrexed—TYMS—Cell Cycle, Mitotic—MAPK3—hematologic cancer	1.01e-05	0.000258	CbGpPWpGaD
Raltitrexed—Rash—Epirubicin—hematologic cancer	1.01e-05	0.000104	CcSEcCtD
Raltitrexed—TYMS—Cell Cycle—EP300—hematologic cancer	1.01e-05	0.000257	CbGpPWpGaD
Raltitrexed—Dermatitis—Epirubicin—hematologic cancer	1.01e-05	0.000104	CcSEcCtD
Raltitrexed—TYMS—Metabolism—GSTP1—hematologic cancer	1.01e-05	0.000256	CbGpPWpGaD
Raltitrexed—Headache—Epirubicin—hematologic cancer	1.01e-05	0.000103	CcSEcCtD
Raltitrexed—TYMS—Cell Cycle, Mitotic—MYC—hematologic cancer	9.87e-06	0.000251	CbGpPWpGaD
Raltitrexed—FPGS—Disease—HRAS—hematologic cancer	9.75e-06	0.000248	CbGpPWpGaD
Raltitrexed—TYMS—Metabolism—ABCB1—hematologic cancer	9.56e-06	0.000243	CbGpPWpGaD
Raltitrexed—Nausea—Epirubicin—hematologic cancer	9.54e-06	9.76e-05	CcSEcCtD
Raltitrexed—Vomiting—Doxorubicin—hematologic cancer	9.45e-06	9.67e-05	CcSEcCtD
Raltitrexed—Rash—Doxorubicin—hematologic cancer	9.37e-06	9.59e-05	CcSEcCtD
Raltitrexed—Dermatitis—Doxorubicin—hematologic cancer	9.36e-06	9.58e-05	CcSEcCtD
Raltitrexed—FPGS—Disease—IL6—hematologic cancer	9.33e-06	0.000237	CbGpPWpGaD
Raltitrexed—Headache—Doxorubicin—hematologic cancer	9.31e-06	9.53e-05	CcSEcCtD
Raltitrexed—TYMS—Metabolism—GSTM1—hematologic cancer	9.28e-06	0.000236	CbGpPWpGaD
Raltitrexed—TYMS—Metabolism—NCOR1—hematologic cancer	9.28e-06	0.000236	CbGpPWpGaD
Raltitrexed—TYMS—Cell Cycle—MAPK3—hematologic cancer	9.07e-06	0.00023	CbGpPWpGaD
Raltitrexed—FPGS—Metabolism—PIK3CA—hematologic cancer	8.83e-06	0.000224	CbGpPWpGaD
Raltitrexed—Nausea—Doxorubicin—hematologic cancer	8.83e-06	9.03e-05	CcSEcCtD
Raltitrexed—TYMS—Cell Cycle—MYC—hematologic cancer	8.82e-06	0.000224	CbGpPWpGaD
Raltitrexed—FPGS—Disease—AKT1—hematologic cancer	8.61e-06	0.000219	CbGpPWpGaD
Raltitrexed—TYMS—Metabolism—MTHFR—hematologic cancer	8.2e-06	0.000208	CbGpPWpGaD
Raltitrexed—TYMS—Cell Cycle—TP53—hematologic cancer	7.24e-06	0.000184	CbGpPWpGaD
Raltitrexed—FPGS—Metabolism—AKT1—hematologic cancer	7.21e-06	0.000183	CbGpPWpGaD
Raltitrexed—TYMS—Metabolism—PIK3CG—hematologic cancer	6.89e-06	0.000175	CbGpPWpGaD
Raltitrexed—TYMS—Metabolism—CREBBP—hematologic cancer	6.39e-06	0.000162	CbGpPWpGaD
Raltitrexed—TYMS—Metabolism—PIK3CD—hematologic cancer	6.06e-06	0.000154	CbGpPWpGaD
Raltitrexed—TYMS—Metabolism—ALB—hematologic cancer	5.98e-06	0.000152	CbGpPWpGaD
Raltitrexed—TYMS—Metabolism—PIK3R1—hematologic cancer	5.72e-06	0.000145	CbGpPWpGaD
Raltitrexed—TYMS—Metabolism—PIK3CB—hematologic cancer	5.28e-06	0.000134	CbGpPWpGaD
Raltitrexed—TYMS—Metabolism—PTEN—hematologic cancer	4.56e-06	0.000116	CbGpPWpGaD
Raltitrexed—TYMS—Metabolism—EP300—hematologic cancer	4.35e-06	0.00011	CbGpPWpGaD
Raltitrexed—TYMS—Metabolism—PIK3CA—hematologic cancer	3.22e-06	8.17e-05	CbGpPWpGaD
Raltitrexed—TYMS—Metabolism—AKT1—hematologic cancer	2.63e-06	6.68e-05	CbGpPWpGaD
